Matt Coffina: For Morningstar StockInvestor, I'm Matt Coffina. I'm joined today by Damien Conover, who is the director of our health-care team. We are going to talk about pharmaceutical firms' pipelines. Damien, thanks for joining me.
Damien Conover: Matt, thanks for having me.
To view this article, become a Morningstar Basic member.
Matthew Coffina has a position in the following securities mentioned above: NVS, ABT, ESRX. Find out about Morningstar’s editorial policies.